|
May 8
|
BrainsWay Reports First Quarter 2024 Financial Results and Operational Highlights
|
|
Mar 28
|
BrainsWay Announces Positive Results in Late-Life Depression Post-Marketing Analysis
|
|
Mar 27
|
After Plunging -13.63% in 4 Weeks, Here's Why the Trend Might Reverse for Brainsway (BWAY)
|
|
Jan 10
|
BrainsWay Initiates Clinical Evaluation of Rotational Field “Deep TMS 360°™” Technology
|
|
Dec 22
|
Are Medical Stocks Lagging Brainsway (BWAY) This Year?
|
|
Dec 19
|
BrainsWay Highlights Expanded Deep TMS™ Access with Growing Western U.S. Network
|
|
Dec 8
|
BrainsWay (BWAY) Strengthens South Korean Foothold With Deep TMS
|
|
Dec 7
|
BrainsWay Announces Continued Expansion of Deep TMS™ in South Korea
|
|
Nov 29
|
Brainsway Ltd. Sponsored ADR (BWAY) Upgraded to Strong Buy: What Does It Mean for the Stock?
|
|
Nov 28
|
Here's Why Momentum in Brainsway Ltd. Sponsored ADR (BWAY) Should Keep going
|
|
Sep 27
|
BrainsWay Announces Presentation of Two Deep TMS™ Posters at Upcoming World Congress of Psychiatry
|
|
Aug 23
|
BrainsWay Further Expands Access to Deep TMS™ in Asia Pacific Region
|